SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-12-034421
Filing Date
2012-06-04
Accepted
2012-06-04 17:22:19
Documents
1
Period of Report
2012-06-01

Document Format Files

Seq Description Document Type Size
1 KOLLINS rrd347299.html 3  
1 KOLLINS rrd347299.xml 3 3101
  Complete submission text file 0001181431-12-034421.txt   4578
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OXIGENE, INC. 230 THIRD AVENUE WALTHAM MA 02451
Business Address
Kollins John A (Reporting) CIK: 0001391070 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51967 | Film No.: 12886971